VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Programnews2025-05-05T07:13:42+00:00May 5th, 2025|Medical Device News Magazine|
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancernews2025-05-05T07:11:12+00:00May 5th, 2025|Medical Device News Magazine|
Choose the Right Tools and Automate Bioprocessing Workflows Hassle-Freenews2025-04-28T19:10:22+00:00April 28th, 2025|Medical Device News Magazine|
Precision for Medicine and PathAI Announce Strategic Collaboration to Advance AI-Powered Clinical Trial Services and Biospecimen Productsnews2025-04-25T17:07:29+00:00April 25th, 2025|Medical Device News Magazine|
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapiesnews2025-04-23T06:15:30+00:00April 23rd, 2025|Medical Device News Magazine|
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinomanews2025-04-21T15:10:47+00:00April 21st, 2025|Medical Device News Magazine|
ARUP Laboratories Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathologynews2025-04-21T13:06:48+00:00April 21st, 2025|Medical Device News Magazine|
PharmaJet® Presents Partner Data Demonstrating that Needle-free Delivery Boosts Immune Response of DNA and Novel Therapeutic Cancer Vaccinesnews2025-04-17T17:57:41+00:00April 17th, 2025|Medical Device News Magazine|
Dyadic to Present at World Vaccine Congress | Washingtonnews2025-04-16T18:17:02+00:00April 16th, 2025|Medical Device News Magazine|
Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Carenews2025-04-16T16:35:53+00:00April 16th, 2025|Medical Device News Magazine|
